Am. J. Respir. Crit. Care Med., Volume 163, Number 3, March 2001, 690-693

Peak Flow as Predictor of Overall Mortality in Asthma and Chronic Obstructive Pulmonary Disease

EJVIND FRAUSING HANSEN, JØRGEN VESTBO, KLAUS PHANARETH, AXEL KOK-JENSEN, and ASGER DIRKSEN

Department of Respiratory Medicine 223, H:S Hvidovre Hospital, Hvidovre; and Department of Respiratory Medicine Y, Gentofte Hospital, Hellerup, Denmark

Lung function is a strong predictor of overall mortality in asthma and chronic obstructive pulmonary disease (COPD). FEV₁ is considered to be the "gold standard," whereas peak expiratory flow (PEF) is mostly used in absence of FEV₁ measurements. We compared the predictive power of PEF and FEV₁, measured after maximal bronchodilation, which included a short course of oral corticosteroids. The study population comprised 491 asthmatics and 1,095 subjects with COPD. Pulmonary function tests were performed between 1983 and 1988, and survival data were obtained by September 1997, when 127 asthmatics and 723 subjects with COPD had died. Predictors of survival were examined by Cox proportional hazards analyses. After controlling for age, smoking, sex, and body mass index, we found best PEF to be at least equal to best FEV₁ as predictor of overall mortality in subjects with COPD. The predictive power of best PEF was in part maintained after controlling for best FEV₁. In asthma, best FEV₁ seemed to be a better predictor of mortality than best PEF. Despite close correlation to FEV₁, PEF apparently provides independent prognostic information in patients with COPD. This may be due to PEF and FEV₁ reflecting different components of COPD, i.e., chronic bronchitis, small airways disease, and emphysema. Furthermore, extrapulmonary components such as muscle mass and general "vigour" probably affect PEF to a greater extent than they affect FEV₁.

This article has been cited by other articles:

				J. N. de Voogd, J. B. Wempe, G. H. Koeter, K. Postema, E. van Sonderen, A. V. Ranchor, J. C. Coyne, and R. Sanderman Depressive Symptoms as Predictors of Mortality in Patients With COPD Chest, March 1, 2009; 135(3): 619 - 625. [Abstract] [Full Text] [PDF]

				V. Bellia, C. Pedone, F. Catalano, A. Zito, E. Davi, S. Palange, F. Forastiere, and R. A. Incalzi Asthma in the Elderly: Mortality Rate and Associated Risk Factors for Mortality Chest, October 1, 2007; 132(4): 1175 - 1182. [Abstract] [Full Text] [PDF]

				A. N. Aggarwal, D. Gupta, and S. K. Jindal The relationship between FEV1 and peak expiratory flow in patients with airways obstruction is poor. Chest, November 1, 2006; 130(5): 1454 - 1461. [Abstract] [Full Text] [PDF]

				J Vestbo, R Pauwels, J A Anderson, P Jones, P Calverley, and on behalf of the TRISTAN study group Early onset of effect of salmeterol and fluticasone propionate in chronic obstructive pulmonary disease Thorax, April 1, 2005; 60(4): 301 - 304. [Abstract] [Full Text] [PDF]

				M. J. TOBIN Chronic Obstructive Pulmonary Disease, Pollution, Pulmonary Vascular Disease, Transplantation, Pleural Disease, and Lung Cancer in AJRCCM 2001 Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 642 - 662. [Full Text] [PDF]